Lv4
460 积分 2023-07-07 加入
Development and therapeutic potential of GSPT1 molecular glue degraders: A medicinal chemistry perspective
2天前
已完结
Design and Discovery of Preclinical Candidate LYG-409 as a Highly Potent and Selective GSPT1 Molecular Glue Degraders
3天前
已完结
Research Progress in Targeting GSPT1: Molecular Glues, Bifunctional Degraders, and Antibody-Enabled Molecular Glues for Cancer Therapy
3天前
已完结
Chemical and Chemoenzymatic Synthesis of Peptide and Protein Therapeutics Conjugated with Human N‐Glycans
1个月前
已完结
Impact of dipeptide on ADC physicochemical properties and efficacy identifies Ala–Ala as the optimal dipeptide
1个月前
已完结
Pediatric Exclusivity-Associated Revenues and Labeling Changes, 2013 to 2023
1个月前
已完结
Interleukin-2 Activity Can Be Fine Tuned with Engineered Receptor Signaling Clamps
1个月前
已关闭
Engineering IL-2 for immunotherapy of autoimmunity and cancer
1个月前
已完结
Biology and regulation of IL-2: from molecular mechanisms to human therapy
1个月前
已完结
Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab
2个月前
已完结
Abstract 2895: Characterization of payload release from a novel camptothecin drug-linker
皖公网安备34019202002308
